APA

Kuijer A., van Bommel A. C. M., Drukker C. A., van der Heiden-van der Loo M., Smorenburg C. H., Westenend P. J., Linn S. C., Rutgers E. J. T., Elias S. G. & van Dalen T. (20170911). Using a gene expression signature when controversy exists regarding the indication for adjuvant systemic treatment reduces the proportion of patients receiving adjuvant chemotherapy: a nationwide study. : Genetics in medicine : official journal of the American College of Medical Genetics.

Chicago

Kuijer A, van Bommel A C M, Drukker C A, van der Heiden-van der Loo M, Smorenburg C H, Westenend P J, Linn S C, Rutgers E J Th, Elias S G and van Dalen Th. 20170911. Using a gene expression signature when controversy exists regarding the indication for adjuvant systemic treatment reduces the proportion of patients receiving adjuvant chemotherapy: a nationwide study. : Genetics in medicine : official journal of the American College of Medical Genetics.

Harvard

Kuijer A., van Bommel A. C. M., Drukker C. A., van der Heiden-van der Loo M., Smorenburg C. H., Westenend P. J., Linn S. C., Rutgers E. J. T., Elias S. G. and van Dalen T. (20170911). Using a gene expression signature when controversy exists regarding the indication for adjuvant systemic treatment reduces the proportion of patients receiving adjuvant chemotherapy: a nationwide study. : Genetics in medicine : official journal of the American College of Medical Genetics.

MLA

Kuijer A, van Bommel A C M, Drukker C A, van der Heiden-van der Loo M, Smorenburg C H, Westenend P J, Linn S C, Rutgers E J Th, Elias S G and van Dalen Th. Using a gene expression signature when controversy exists regarding the indication for adjuvant systemic treatment reduces the proportion of patients receiving adjuvant chemotherapy: a nationwide study. : Genetics in medicine : official journal of the American College of Medical Genetics. 20170911.